JPS5429508B2 - - Google Patents

Info

Publication number
JPS5429508B2
JPS5429508B2 JP5689873A JP5689873A JPS5429508B2 JP S5429508 B2 JPS5429508 B2 JP S5429508B2 JP 5689873 A JP5689873 A JP 5689873A JP 5689873 A JP5689873 A JP 5689873A JP S5429508 B2 JPS5429508 B2 JP S5429508B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP5689873A
Other languages
Japanese (ja)
Other versions
JPS4948676A (enExample
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4948676A publication Critical patent/JPS4948676A/ja
Publication of JPS5429508B2 publication Critical patent/JPS5429508B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP5689873A 1972-05-23 1973-05-23 Expired JPS5429508B2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24732/72A IT1044222B (it) 1972-05-23 1972-05-23 Bifenilil alcanoilaminopiridine ad attivita anti infiammatoria di lunga durata

Publications (2)

Publication Number Publication Date
JPS4948676A JPS4948676A (enExample) 1974-05-11
JPS5429508B2 true JPS5429508B2 (enExample) 1979-09-25

Family

ID=11214555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5689873A Expired JPS5429508B2 (enExample) 1972-05-23 1973-05-23

Country Status (19)

Country Link
US (1) US3868380A (enExample)
JP (1) JPS5429508B2 (enExample)
AR (1) AR196130A1 (enExample)
AU (1) AU469305B2 (enExample)
BE (1) BE799841A (enExample)
BR (1) BR7303772D0 (enExample)
CA (1) CA978970A (enExample)
CH (1) CH605766A5 (enExample)
DD (1) DD108083A5 (enExample)
DK (1) DK142948C (enExample)
ES (1) ES415000A1 (enExample)
FR (1) FR2185410B1 (enExample)
GB (1) GB1380225A (enExample)
IT (1) IT1044222B (enExample)
LU (1) LU67624A1 (enExample)
NL (1) NL151366B (enExample)
NO (1) NO138999C (enExample)
SE (1) SE382053B (enExample)
YU (1) YU35243B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8003120A (nl) * 1979-05-30 1980-12-02 Italiana Schoum Spa Difenylpropylaminopyridineverbindingen, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
FR2514355A1 (fr) * 1981-10-14 1983-04-15 Fabre Sa Pierre Derives de biphenyl alcoyl carboxylates, leur procede de preparation et leur utilisation comme medicaments
US4600649A (en) * 1984-10-22 1986-07-15 Desoto, Inc. Abrasion-resistant ultraviolet-curable coatings
US7968574B2 (en) * 2004-12-28 2011-06-28 Kinex Pharmaceuticals, Llc Biaryl compositions and methods for modulating a kinase cascade
AU2005321966B2 (en) * 2004-12-28 2011-11-17 Atnx Spv, Llc Compositions and methods of treating cell proliferation disorders
JP5564251B2 (ja) * 2006-06-29 2014-07-30 キネックス ファーマシューティカルズ, エルエルシー キナーゼカスケードを調節するためのビアリール組成物および方法
TWI457336B (zh) * 2006-12-28 2014-10-21 Kinex Pharmaceuticals Llc 調節激酶級聯之組成物及方法
US7935697B2 (en) 2006-12-28 2011-05-03 Kinex Pharmaceuticals, Llc Compositions for modulating a kinase cascade and methods of use thereof
US7939529B2 (en) * 2007-05-17 2011-05-10 Kinex Pharmaceuticals, Llc Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof
WO2009009041A2 (en) * 2007-07-06 2009-01-15 Kinex Pharmaceuticals, Llc Compositions and methods for modulating a kinase cascade
ES2842334T3 (es) * 2007-10-20 2021-07-13 Athenex Inc Composiciones farmacéuticas para modular una cascada de cinasas y métodos de uso de las mismas
EP2558085B1 (en) 2010-04-16 2017-08-30 Athenex, Inc. Compositions and methods for the prevention and treatment of cancer
CN105263907B (zh) 2012-08-30 2018-11-20 阿西纳斯公司 作为蛋白质酪氨酸激酶调节剂的n-(3-氟苄基)-2-(5-(4-吗啉代苯基)吡啶-2-基)乙酰胺
AU2018380132B2 (en) * 2017-12-06 2023-11-09 Lin Bioscience, Inc. Tubulin inhibitors
EP4230196A1 (en) 2022-02-21 2023-08-23 Som Innovation Biotech, S.A. Compounds for use in the treatment of dystrophinopathies

Also Published As

Publication number Publication date
DD108083A5 (enExample) 1974-09-05
AU469305B2 (en) 1976-02-12
DE2325309B2 (de) 1976-01-29
FR2185410B1 (enExample) 1976-05-14
NO138999C (no) 1978-12-20
LU67624A1 (enExample) 1973-08-02
NL7307114A (enExample) 1973-11-27
CH605766A5 (enExample) 1978-10-13
AU5583373A (en) 1974-11-21
AR196130A1 (es) 1973-11-30
DK142948B (da) 1981-03-02
JPS4948676A (enExample) 1974-05-11
ES415000A1 (es) 1976-06-01
NO138999B (no) 1978-09-11
CA978970A (en) 1975-12-02
BE799841A (fr) 1973-09-17
YU133872A (en) 1980-04-30
FR2185410A1 (enExample) 1974-01-04
BR7303772D0 (pt) 1974-08-29
GB1380225A (en) 1975-01-08
DE2325309A1 (de) 1973-12-06
NL151366B (nl) 1976-11-15
US3868380A (en) 1975-02-25
DK142948C (da) 1981-10-05
YU35243B (en) 1980-10-31
IT1044222B (it) 1980-03-20
SE382053B (sv) 1976-01-12

Similar Documents

Publication Publication Date Title
JPS5429508B2 (enExample)
JPS5037734B2 (enExample)
CS153945B1 (enExample)
CS153284B1 (enExample)
CS153935B1 (enExample)
CS153931B1 (enExample)
CS153726B1 (enExample)
CS153432B2 (enExample)
CS153294B1 (enExample)
CS151848B1 (enExample)
CS152982B2 (enExample)
CS153948B1 (enExample)
CS152733B1 (enExample)
CS152722B1 (enExample)
CS152719B1 (enExample)
CS152246B1 (enExample)
CS152200B1 (enExample)
CH560025A5 (enExample)
CH589413A5 (enExample)
CH567700A5 (enExample)
CH567892A5 (enExample)
CH567943A5 (enExample)
CH568755A5 (enExample)
CH569446A5 (enExample)
CH575384A5 (enExample)